Nanobiotix S.A. (0QAV.L)

EUR 3.0

(0.33%)

Long Term Debt Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual long term debt in 2023 was 41.66 Million EUR , down -5.4% from previous year.
Nanobiotix S.A.'s latest quarterly long term debt in 2024 Q2 was 40.72 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported annual long term debt of 44.04 Million EUR in 2022, up 35.83% from previous year.
Nanobiotix S.A. reported annual long term debt of 32.42 Million EUR in 2021, down -17.11% from previous year.
Nanobiotix S.A. reported quarterly long term debt of 41.66 Million EUR for 2023 FY, down -5.4% from previous quarter.
Nanobiotix S.A. reported quarterly long term debt of 45.54 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Long Term Debt of Nanobiotix S.A. (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	41.66 Million EUR	-5.4%
2022	44.04 Million EUR	35.83%
2021	32.42 Million EUR	-17.11%
2020	39.11 Million EUR	3.97%
2019	37.62 Million EUR	87.91%
2018	20.02 Million EUR	405.61%
2017	3.95 Million EUR	-13.6%
2016	4.58 Million EUR	29.8%
2015	3.53 Million EUR	76.36%
2014	2 Million EUR	128.76%
2013	875.17 Thousand EUR	-18.37%
2012	1.07 Million EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	40.72 Million EUR	0.0%
2023 FY	41.66 Million EUR	-5.4%
2023 Q4	45.54 Million EUR	0.0%
2023 Q2	39.92 Million EUR	0.0%
2022 Q4	44.04 Million EUR	0.0%
2022 Q2	31.14 Million EUR	0.0%
2022 FY	44.04 Million EUR	35.83%
2021 FY	32.42 Million EUR	-17.11%
2021 Q4	32.42 Million EUR	0.0%
2021 Q2	39.13 Million EUR	0.0%
2020 Q2	44.06 Million EUR	0.0%
2020 FY	39.11 Million EUR	3.97%
2020 Q4	39.11 Million EUR	0.0%
2019 Q4	37.62 Million EUR	0.0%
2019 FY	37.62 Million EUR	87.91%
2019 Q2	35.89 Million EUR	0.0%
2018 FY	20.02 Million EUR	405.61%
2018 Q4	20.02 Million EUR	0.0%
2018 Q2	3.79 Million EUR	0.0%
2017 FY	3.95 Million EUR	-13.6%
2017 Q4	3.74 Million EUR	0.0%
2017 Q2	4.07 Million EUR	0.0%
2016 Q2	3.01 Million EUR	0.0%
2016 FY	4.58 Million EUR	29.8%
2016 Q4	4.58 Million EUR	0.0%
2015 Q4	3.53 Million EUR	0.0%
2015 Q2	3.51 Million EUR	0.0%
2015 FY	3.53 Million EUR	76.36%
2014 FY	2 Million EUR	128.76%
2014 Q4	2 Million EUR	0.0%
2014 Q2	1.1 Million EUR	0.0%
2013 FY	875.17 Thousand EUR	-18.37%
2013 Q4	875.17 Thousand EUR	0.0%
2013 Q2	929.08 Thousand EUR	0.0%
2012 Q4	1.07 Million EUR	0.0%
2012 Q3	1.07 Million EUR	0.0%
2012 FY	1.07 Million EUR	0.0%

Peer Long Term Debt Comparison of Nanobiotix S.A.

Name	Long Term Debt	Long Term Debt Difference
Boiron SA	6.64 Million EUR	-526.938%
Laboratorios Farmaceuticos Rovi, S.A.	38.57 Million EUR	-7.997%
Vetoquinol SA	9.66 Million EUR	-331.129%
Valneva SE	132.76 Million EUR	68.622%
AB Science S.A.	16.98 Million EUR	-145.232%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	-492.603%
Vivoryon Therapeutics N.V.	- EUR	-Infinity%
BioSenic S.A.	15.57 Million EUR	-167.514%
ABIVAX Société Anonyme	44.69 Million EUR	6.795%
Formycon AG	7.81 Million EUR	-433.077%